Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

In a recent interview, FDA Commissioner Marty Makary said there “should be nothing political about the FDA.” Recent actions ...

The Trump administration on Monday announced federal officials are launching investigations into Harvard University and the ...

At the insistence of Justice Neil Gorsuch, she withdrew the allegation that the other side had lied but held firm to the ...

The coal industry once provided more than half of U.S. electricity production. But it has been in steep decline for decades ...

Novavax is working with the FDA to meet additional requirements and hopes to secure full approval as soon as possible.

‘Many failures’: FDA whistleblower spills on DEI and bad practices during Biden administration Fox News Digital spoke to former FDA official David Oliveira about the FDA’s tobacco chief ...

Novavax has not received an official response from the FDA related to the status of the BLA. The BLA was based on data from a phase III study, which showed the vaccine was safe and effective for ...

When asked if the delay resulted from "personnel being shuffled" at the FDA, Kennedy attributed it to the vaccine's composition. He said Novavax's single antigen approach "has never worked" for ...

By Kamal Choudhury (Reuters) -Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services Secretary Robert F. Kennedy Jr. raised concerns about ...

This news follows Novavax's announcement last week that it is still awaiting a decision from the FDA regarding its Covid-19 vaccine approval application. Kennedy clarified that the delay in ...